Phoska Biopharma is advancing new therapies for treating liver and metabolic conditions such as Fatty Liver/NASH and cardiovascular health. It does this by leveraging a breakthrough discovery in lipid metabolism able to engage specific cells to deliver treatment. (Note: some form of these metabolic diseases affect are over 1 Billion people in the world)

Focus of Therapeutic Area: Liver & Kidney (Metabolic conditions)